Literature DB >> 17562621

Interphase fluorescence in situ hybridization detection of cytogenetic abnormalities in B-cell chronic lymphocytic leukemia.

Wei Xu1, Jian-Yong Li, Jin-Lan Pan, Hai-Rong Qiu, Yun-Feng Shen, Li Li, Ya-Fang Wu, Yong-Quan Xue.   

Abstract

The most frequent chromosomal abnormalities in B-cell chronic lymphocytic leukemia (B-CLL) are deletions on 13q14 and 17p13, trisomy 12, and 14q32 rearrangement. Conventional cytogenetic analysis underestimates the frequency of specific chromosome aberrations in B-CLL because of the low rate of spontaneous mitoses and the poor response to mitogen stimulation. We used interphase fluorescence in situ hybridization (I-FISH) to explore the incidence of chromosomal changes in the peripheral blood cells of B-CLL patients. Probes for 13q14 (D13S319), 17p13 (p53), the centromere of chromosome 12 (CEP12), and 14q32 (IGHC/IGHV) were applied to detect chromosomal aberrations in peripheral blood samples from 83 B-CLL patients (60 men, 23 women). Molecular cytogenetic aberrations were found in 61 cases (73.5%), and 8 patients (9.6%) showed 2 kinds of abnormalities. The most frequent abnormality was deletion of 13q14 (41.0%), followed by +12 (19.3%), deletion of 17p13 (12%), and 14q32 rearrangement (9.6%). FISH results were analyzed for correlation with Binet stages. The percentages of patients who showed abnormalities by FISH were 73.0%, 73.3%, and 80% for Binet stages A, B, and C, respectively, and the percentages of patients with abnormalities who showed 2 anomalies were 7.9%, 27.3%, and 0% for Binet stages A, B, and C, respectively. We noted no consistent pattern among the various Binet stages in the distribution of either the types of FISH-detected anomalies or the numbers of FISH anomalies. I-FISH was found to be a rapid, exact, and sensitive technique for analysis of chromosome aberrations in CLL. FISH could provide accurate information regarding the molecular cytogenetic features of CLL.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17562621     DOI: 10.1532/IJH97.A10602

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  22 in total

Review 1.  Fluorescence in situ hybridization: uses and limitations.

Authors:  A Gozzetti; M M Le Beau
Journal:  Semin Hematol       Date:  2000-10       Impact factor: 3.851

Review 2.  Genetics of chronic lymphocytic leukemia: genomic aberrations and V(H) gene mutation status in pathogenesis and clinical course.

Authors:  S Stilgenbauer; L Bullinger; P Lichter; H Döhner
Journal:  Leukemia       Date:  2002-06       Impact factor: 11.528

Review 3.  Molecular genetics and its clinical relevance.

Authors:  Stephan Stilgenbauer; Hartmut Döhner
Journal:  Hematol Oncol Clin North Am       Date:  2004-08       Impact factor: 3.722

4.  A clinical staging system for chronic lymphocytic leukemia: prognostic significance.

Authors:  J L Binet; M Leporrier; G Dighiero; D Charron; P D'Athis; G Vaugier; H M Beral; J C Natali; M Raphael; B Nizet; J Y Follezou
Journal:  Cancer       Date:  1977-08       Impact factor: 6.860

Review 5.  Cytogenetics in chronic lymphocytic leukemia.

Authors:  G Juliusson; M Merup
Journal:  Semin Oncol       Date:  1998-02       Impact factor: 4.929

6.  Prognostic relevance of monosomy at the 13q14 locus detected by fluorescence in situ hybridization in B-cell chronic lymphocytic leukemia.

Authors:  W J Hogan; A Tefferi; T J Borell; R Jenkins; C Y Li; T E Witzig
Journal:  Cancer Genet Cytogenet       Date:  1999-04-15

Review 7.  Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analysis.

Authors:  H Döhner; S Stilgenbauer; K Döhner; M Bentz; P Lichter
Journal:  J Mol Med (Berl)       Date:  1999-02       Impact factor: 4.599

8.  Fluorescent in situ hybridization and cytogenetic studies of trisomy 12 in chronic lymphocytic leukemia.

Authors:  S M Escudier; J M Pereira-Leahy; J W Drach; H U Weier; A M Goodacre; M A Cork; J M Trujillo; M J Keating; M Andreeff
Journal:  Blood       Date:  1993-05-15       Impact factor: 22.113

9.  Trisomy 12 and structural abnormalities of 13q14 occurring in the same clone in chronic lymphocytic leukaemia.

Authors:  S Mould; A Gardiner; M Corcoran; D G Oscier
Journal:  Br J Haematol       Date:  1996-02       Impact factor: 6.998

Review 10.  A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.

Authors:  N L Harris; E S Jaffe; H Stein; P M Banks; J K Chan; M L Cleary; G Delsol; C De Wolf-Peeters; B Falini; K C Gatter
Journal:  Blood       Date:  1994-09-01       Impact factor: 22.113

View more
  7 in total

1.  Association between polymorphism of CD20 gene and chronic lymphocytic leukemia in Chinese population.

Authors:  Cheng Fang; Dan-Xia Zhu; Li Wang; Lei Fan; Ji Xu; Jia-Zhu Wu; Ting-Xun Lu; Jian-Yong Li; Chang-Ping Wu; Wei Xu
Journal:  Int J Clin Exp Med       Date:  2015-07-15

2.  Immunoglobulin gene translocations in chronic lymphocytic leukemia: A report of 35 patients and review of the literature.

Authors:  Marc DE Braekeleer; Corine Tous; Nadia Guéganic; Marie-Josée LE Bris; Audrey Basinko; Frédéric Morel; Nathalie Douet-Guilbert
Journal:  Mol Clin Oncol       Date:  2016-02-26

3.  t(14;18)(q32;q21) in chronic lymphocytic leukemia patients: Report of two cases and a literature review.

Authors:  Weifeng Chen; Yi Miao; Rong Wang; Yujie Wu; Hairong Qiu; Wei Xu; Jianyong Li; Lei Fan; Xin Xu
Journal:  Oncol Lett       Date:  2016-10-13       Impact factor: 2.967

4.  Distinct molecular genetics of chronic lymphocytic leukemia in Taiwan: clinical and pathogenetic implications.

Authors:  Shang-Ju Wu; Chien-Ting Lin; Andreas Agathangelidis; Liang-In Lin; Yuan-Yeh Kuo; Hwei-Fang Tien; Paolo Ghia
Journal:  Haematologica       Date:  2017-03-02       Impact factor: 9.941

5.  BCL-2 and MYC gain/amplification is correlated with central nervous system involvement in diffuse large B cell lymphoma at leukemic phase.

Authors:  Dehui Zou; Shuhua Yi; Rui Cui; Wei Liu; Chengwen Li; Shizhen Zhong; Zhen Yu; Zengjun Li; Rui Lv; Kun Ru; Huijun Wang; Gang An; Yan Xu; Lugui Qiu
Journal:  BMC Med Genet       Date:  2017-02-16       Impact factor: 2.103

6.  Presence of serum antinuclear antibodies correlating unfavorable overall survival in patients with chronic lymphocytic leukemia.

Authors:  Qian Sun; Li Wang; Hua-Yuan Zhu; Yi Miao; Wei Wu; Jin-Hua Liang; Lei Cao; Yi Xia; Jia-Zhu Wu; Yan Wang; Rong Wang; Lei Fan; Wei Xu; Jian-Yong Li
Journal:  Chin Med J (Engl)       Date:  2019-03-05       Impact factor: 2.628

7.  Diabetes Mellitus Is Associated with Inferior Prognosis in Patients with Chronic Lymphocytic Leukemia: A Propensity Score-Matched Analysis.

Authors:  Rui Gao; Tian-Shuo Man; Jin-Hua Liang; Li Wang; Hua-Yuan Zhu; Wei Wu; Lei Fan; Jian-Yong Li; Tao Yang; Wei Xu
Journal:  Cancer Res Treat       Date:  2019-07-01       Impact factor: 4.679

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.